Evidence map›Paper›PMID 41926517›Full record

ArticleInfection and drug resistance2026

Marked Non-Infectious Elevation of Procalcitonin in a Hemodialysis Patient with Bladder Cancer: A Case Report.

Yuan Cong Yan, Qiang Guo, Jingjing Xu, Zhe Wei, Junyun Li

Abstract readCase Reports
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuan Cong YanDepartment of Pharmacy, Jincheng People's Hospital, Jincheng, People's Republic of China.ORCID 0009-0002-7243-998X
Qiang GuoDepartment of Pharmacy, Jincheng People's Hospital, Jincheng, People's Republic of China.
Jingjing XuDepartment of Pharmacy, Jincheng People's Hospital, Jincheng, People's Republic of China.ORCID 0009-0001-5995-7275
Zhe WeiDepartment of Pharmacy, Jincheng People's Hospital, Jincheng, People's Republic of China.
Junyun LiDepartment of Pharmacy, Jincheng People's Hospital, Jincheng, People's Republic of China.ORCID 0009-0008-1853-2677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Here, we present a rare case of a sustained hemodialysis patient with bladder cancer who had the marked elevation of procalcitonin (PCT) in the absence of evidence for infection. Case Presentation: A patient had significantly elevated PCT but without clinical manifestations of infection. Through evidence-based investigation and collaboration with physicians, clinical pharmacists successfully ruled out infection. Consequently, antibiotics were discontinued, and the patient improved and was discharged from the hospital. Conclusion: The aim is to remind clinical pharmacists and clinicians to conduct comprehensive examination and judgment when encountering similar cases to reduce the occurrence of misdiagnosis in clinical practice.

Indexed as

C-reactive proteinend-stage renal diseasepharmaceutical careprocalcitoninsepsis

Identifiers

PMID41926517
PMCPMC12790762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.